Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep134a | Bone & Osteoporosis | ECE2016

Depression, Obesity, and Elbow Fracture: a Pathogenic Triangle?

Carsote Mara , Radoi Valentin , Valea Ana , Albu Simona Elena , Vasiliu Cristina , Ghemigian Adina

Introduction: Depression and associated medication, especially Selective Serotonin Reuptake Inhibitors, may associate high fracture risk through serotonin (but not only). Obesity has been recently proved to be correlated with a higher fracture risk for a few sites as ankle, elbow, shoulder, etc. Moreover, depression and some anti-depressants may increase the calories intake and consecutive increased of Body Mass Index (BMI) is registered.Aim: We present ...

ea0035p86 | Bone and Osteoporosis | ECE2014

The 10-year absolute fracture risk and central DXA correlations in 505 Romanian menopausal women

Carsote Mara , Radoi Valentin , Mihai Alexandra , Geleriu Andreea , Baciu Ionela , Capatana Cristina , Paun Diana , Poiana Catalina

Introduction: The new tool FRAX indicated risk of fracture, using or not DXA which is the golden standard for osteoporosis diagnosis.Aim: We analyzed the lumbar DXA correlations with 10-year fragility fracture risk probability.Material and method: A cross sectional study in postmenopausal women was designed. They were osteoporosis free at baseline; none of them has previously been treated for osteoporosis. The anamnesis, the anthro...

ea0032p98 | Bone and Osteoporosis | ECE2013

The follow-up in patients evaluated based on quantitative ultrasound: a prospective study

Carsote Mara , Radoi Valentin , Popescu Mihaela , Dusceac Roxana , Ene Cristina , Voicu Gabriela , Coculescu Mihail , Poiana Catalina

Introduction: The heel quantitative ultrasound (QUS) is useful tool in the assessment of fracture risk especially if cost issues are involved. It might be helpful in follow-up the patients who will not be treated with anti-osteoporotic drugs.Aim: To present the bone evaluation (DXA) after a period of time in patients who are initially assesed by both DXA and QUS.Material and patients: This is a prospective pilot study in a group of...

ea0026p547 | Bone/calcium/Vitamin D | ECE2011

The QUS fracture risk groups: unifactorial analyze regarding bone markers and DXA assessment

Carsote Mara , Chirita Corina , Radoi Valentin , Ene Cristina , Gruia Adriana , Voicu Gabriela , Poiana Catalina , Coculescu Mihail

Introduction: The quantitative ultrasound (QUS) is an useful tool in the evaluation of the fragility fracture risk.Aim and study design: We performed the QUS fragility fracture risk groups (valided by the golden standard DXA) by a unifactorial analyze including the bone markers.Method: The cut offs used were: SI≤59U (high risk), SI≥83U (low risk), and medium risk with SI between 59 and 83U. The QUS analyze was performed...

ea0035p85 | Bone and Osteoporosis | ECE2014

The total fat mass and the fracture risk assessment: a study in 146 Romanian menopausal women

Carsote Mara , Radoi Valentin , Mihai Alexandra , Geleriu Andreea , Miulescu Rucsandra Danciulescu , Capatana Cristina , Trifanescu Raluca , Poiana Catalina

Introduction: The fat mass (FM) is assessed by DXA, magnetic resonance, etc. One of the most accessible methods for current practice is bioimpedance.Aim: We analyzed FM based on bioimpedance and fragility fracture risk.Material and method: This is a transversal study in women, admitted at C.I.Parhon National Institute of Endocrinology, Bucharest, Romania. The inclusion criteria were women in menopause. The exclusion criteria were p...

ea0022p541 | Male reproduction | ECE2010

The effect of undecanoat testosterone depot on the prostate volume

Peretianu Dan , Carsote Mara , Clodeanu Alexandrina , Staicu Dana Cristina , Chirita Corina , Ene Cristina , Radoi Valentin , Poiana Catalina

Introduction: Testosterone therapy in elderly is controversial, because of the effect on prostate. The old age itself is not a contraindication in the therapy of hypogonadism.Aim: We analyze the effect of 24 months of therapy with testosterone undecanoat depot (1000 mg/4 ml) (TUD) on the volume of the prostate (VP).Patients and method: The patients were 79 symptomatic hypogonadic men, with normal value of PSA (<4 g/l). The urol...

ea0022p851 | Thyroid | ECE2010

Drug induced hyperthyroidism (a rare reaction of sorafenib): case report

Peretianu Dan , Carsote Mara , Clodeanu Alexandrina , Staicu Dana Cristina , Chirita Corina , Terzea Dana , Radoi Valentin , Poiana Catalina

Introduction: Sorafenib, an orphan medication, is an oral protein kinase inhibitor, used in the treatment of hepatic, advanced renal and breast cancer, or metastatic iodine-refractary thyroid cancer. The drug also inhibits angiogenesis, and VEGF, having a dual effect on the tumor cells as well as on the tumor vasculature.Aim: We present a case with hyperthyroidism, as adverse effect of the therapy with sorafenib, but with no markers of thyroid autoimmuni...